EUVIMEDEUVIMED entdecken
Crossref

Serum Neurofilament Light Chain in the Diagnostic Evaluation of Patients with Cognitive Symptoms in the Neurological Consultation of a Tertiary Center

Pedro Lopes das Neves, João Durães, Anuschka Silva-Spinola, Marisa Lima, Maria João Leitão, Miguel Tábuas-Pereira, Isabel Santana, Inês Baldeiras

Journal of Alzheimer's Disease · 2023

DOI: 10.3233/jad-221208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2023. Verfasst von Pedro Lopes das Neves und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Hospital Professor Doutor Fernando Fonseca, Lisboa, Portugal. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serum light-chain neurofilaments (sNfL) have been investigated as a potential minimally invasive biomarker that could help in the diagnosis of patients with cognitive symptoms. We assessed the correlation between sNfL and cerebrospinal fluid (CSF) biomarkers (sNfL versus CSF NfL, ρ= 0.70, p < 0.001), the performance of sNfL in distinguishing controls from patients (controls versus frontotemporal dementia, area under curve 0.86), and sNfL differences in mild cognitive impairment according to amyloid-β (Aβ) deposition (Aβ versus non-Aβ, p = 0.017). Our results support the role of this biomarker in the screening and risk stratification of patients followed in a neurological consultation of a tertiary center.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionHumanstau ProteinsIntermediate FilamentsNeurofilament ProteinsAmyloid beta-PeptidesCognitionBiomarkers

Stichwörter der Autor:innen

Alzheimer’s diseasebiomarkersfrontotemporal dementiamild cognitive impairmentneurofilament light chain

Substanzen

tau ProteinsNeurofilament ProteinsAmyloid beta-PeptidesBiomarkers

Autor:innen und Institutionen

  • Neurology Department, Hospital Professor Doutor Fernando Fonseca, Lisboa, Portugal.
  • Neurology Department, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal.
  • Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Centre for Innovative Biomedicine and Biotechnology (CIBB), Universidade de Coimbra, Coimbra, Portugal.

Zitieren

APA

Lopes das Neves, P., Durães, J., Silva-Spinola, A., Lima, M., Leitão, M. J., Tábuas-Pereira, M., Santana, I., & Baldeiras, I. (2023). Serum Neurofilament Light Chain in the Diagnostic Evaluation of Patients with Cognitive Symptoms in the Neurological Consultation of a Tertiary Center. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-221208

Vancouver

Lopes das Neves P, Durães J, Silva-Spinola A, Lima M, Leitão MJ, Tábuas-Pereira M, et al. Serum Neurofilament Light Chain in the Diagnostic Evaluation of Patients with Cognitive Symptoms in the Neurological Consultation of a Tertiary Center. Journal of Alzheimer's Disease. 2023. doi:10.3233/jad-221208

BibTeX
@article{LopesdasNeves2023,
  author = {Lopes das Neves, Pedro and Durães, João and Silva-Spinola, Anuschka and Lima, Marisa and Leitão, Maria João and Tábuas-Pereira, Miguel and Santana, Isabel and Baldeiras, Inês},
  title = {Serum Neurofilament Light Chain in the Diagnostic Evaluation of Patients with Cognitive Symptoms in the Neurological Consultation of a Tertiary Center},
  journal = {Journal of Alzheimer's Disease},
  year = {2023},
  doi = {10.3233/jad-221208}
}
Kostenlos starten →